uniQure
QURE
#5325
Rank
C$2.31 B
Marketcap
C$33.42
Share price
0.39%
Change (1 day)
-56.37%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of June 2026 : C$1.15 Billion

According to uniQure's latest financial reports the company has C$1.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$0.85 B61.66%
2024-12-31C$0.52 B-35.65%
2023-12-31C$0.81 B71.17%
2022-12-31C$0.47 B-32.46%
2021-12-31C$0.70 B126.99%
2020-12-31C$0.31 B-36.71%
2019-12-31C$0.49 B54.2%
2018-12-31C$0.31 B59.69%
2017-12-31C$0.20 B12.53%
2016-12-31C$0.17 B-42.08%
2015-12-31C$0.30 B309.37%
2014-12-31C$75.1 M114.58%
2013-12-31C$34.99 M10019.15%
2012-12-31C$0.34 M-76.15%
2011-12-31C$1.45 M-93.89%
2010-12-31C$23.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
C$19.93 B 1,626.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.32 B 794.38%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
C$39.3 M-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
C$0.11 B-90.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.24 B 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$2.41 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA